Arvinas, Inc. ROE
Profitability, historical returns, and peer comparisons.
The ROE as of November 2026 (TTM) for Arvinas, Inc. (ARVN) is -2.00%
According to Arvinas, Inc.’s latest financial reports and current stock price. The company's current ROE is -2.00%. This represents a change of -25.71% compared to the average of -2.70% of the last 4 quarters.
Arvinas, Inc. (ARVN) Historical ROE (quarterly & annually)
How has ARVN ROE performed in the past?
The mean historical ROE of Arvinas, Inc. over the last ten years is -1010.51%. The current -2.00% ROE has changed -99.80% with respect to the historical average. Over the past ten years (40 quarters), ARVN's ROE was at its highest in in the June 2026 quarter at 30.13%. The ROE was at its lowest in in the December 2017 quarter at -1922.98%.
Average
-1010.51%
Median
-33.21%
Minimum
-9781.27%
Maximum
-18.58%
Arvinas, Inc. (ARVN) ROE by Quarter and Year
Discovering the peaks and valleys of Arvinas, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 16.28%
Maximum Annual ROE = -18.58%
Minimum Annual Increase = -99.69%
Minimum Annual ROE = -9781.27%
| Year | ROE | Change |
|---|---|---|
| 2025 | -18.63% | -47.40% |
| 2024 | -35.41% | -36.37% |
| 2023 | -55.65% | 11.28% |
| 2022 | -50.01% | 104.67% |
| 2021 | -24.43% | 31.53% |
| 2020 | -18.58% | -40.09% |
| 2019 | -31.01% | 2.16% |
| 2018 | -30.35% | -99.69% |
| 2017 | -9781.27% | 16.28% |
Arvinas, Inc. (ARVN) Average ROE
How has ARVN ROE performed in the past?
The current ROE of Arvinas, Inc. (ARVN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-36.56%
5-year avg
-36.83%
10-year avg
-1010.51%
Arvinas, Inc. (ARVN) ROE vs. Peers
How is ARVN’s ROE compared to its peers?
Arvinas, Inc.’s ROE is greater than C4 Therapeutics, Inc. (-45.45%), greater than Kymera Therapeutics, Inc. (-22.39%), greater than Monte Rosa Therapeutics, Inc. (-43.31%), less than Nurix Therapeutics, Inc. (49.34%), less than Foghorn Therapeutics Inc. (72.64%),
| Company | ROE | Market cap |
|---|---|---|
| -45.45% | $383.84M | |
| -22.39% | $11.63B | |
| -43.31% | $923.09M | |
| 49.34% | $1.74B | |
| 72.64% | $124.71M |
Build a custom stock screener for Arvinas, Inc. (ARVN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arvinas, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Arvinas, Inc. (ARVN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Arvinas, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Arvinas, Inc.'s ROE?
How is the ROE calculated for Arvinas, Inc. (ARVN)?
What is the highest ROE for Arvinas, Inc. (ARVN)?
What is the 3-year average ROE for Arvinas, Inc. (ARVN)?
What is the 5-year average ROE for Arvinas, Inc. (ARVN)?
How does the current ROE for Arvinas, Inc. (ARVN) compare to its historical average?